Brendan Loftus

Brendan Loftus has a diverse work experience in the pharmaceutical and biotech industry. Brendan is currently working as the Director of New Product Planning at Kymera Therapeutics since 2023. Prior to that, they held the position of Director of Corporate Strategy at EQRx from 2022 to 2023, and before that, they worked as the Associate Director of Corporate Strategy at EQRx from 2020 to 2022. Brendan also served as the Senior Manager of Corporate Development at Decibel Therapeutics from 2019 to 2020.

Earlier in their career, Brendan worked at Health Advances in various roles including Engagement Manager from 2018 to 2019, Consultant from 2017 to 2018, Senior Analyst from 2016 to 2017, and Analyst from 2014 to 2015. Brendan started their career as a New Product Planning Intern at Alkermes in 2013. Brendan also has experience as a Lab Assistant at The Geisel School of Medicine at Dartmouth from 2011 to 2013, where they worked on determining the role of microglial cells in Alzheimer's disease.

Brendan Loftus attended Dartmouth College from 2010 to 2014, where they earned an AB degree in Biological Chemistry and Economics.